NewAmsterdam Pharma Co N.V. financial data

Symbol
NAMS, NAMSW on Nasdaq
Location
Gooimeer 2 35, Narrden, Netherlands
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 5, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.31K % +49.8%
Debt-to-equity 7.99 % -54%
Return On Equity -29.1 % +46.4%
Return On Assets -26.9 % +41.8%
Operating Margin -576 % -5.05%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 113M shares +22.7%
Common Stock, Shares, Outstanding 113M shares +22.8%
Entity Public Float 1.05B USD +82.1%
Common Stock, Value, Issued 14.1M USD +23.4%
Weighted Average Number of Shares Outstanding, Basic 119M shares +25.6%
Weighted Average Number of Shares Outstanding, Diluted 119M shares +25.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 35.2M USD +4.91%
Research and Development Expense 138M USD -12.5%
General and Administrative Expense 15M USD -27%
Operating Income (Loss) -203M USD -10.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -221M USD -11.2%
Income Tax Expense (Benefit) -1K USD
Net Income (Loss) Attributable to Parent -221M USD -11.1%
Earnings Per Share, Basic -2 USD/shares +10.7%
Earnings Per Share, Diluted -2 USD/shares +10.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 538M USD +27.4%
Marketable Securities, Current 165M USD
Assets, Current 732M USD +67.2%
Property, Plant and Equipment, Net 323K USD +39.8%
Operating Lease, Right-of-Use Asset 246K USD -50.1%
Assets 786M USD +79.1%
Accounts Payable, Current 3.63M USD -48.4%
Liabilities, Current 58.3M USD +41.2%
Operating Lease, Liability, Noncurrent 85K USD -68%
Liabilities 58.4M USD -3.27%
Accumulated Other Comprehensive Income (Loss), Net of Tax 4.64M USD +4.93%
Retained Earnings (Accumulated Deficit) -687M USD -47.4%
Stockholders' Equity Attributable to Parent 728M USD +92.2%
Liabilities and Equity 786M USD +79.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -36.5M USD +33.2%
Net Cash Provided by (Used in) Financing Activities 6.52M USD -96.7%
Net Cash Provided by (Used in) Investing Activities 2.86M USD
Common Stock, Shares Authorized 400M shares 0%
Common Stock, Shares, Issued 113M shares +22.8%
Common Stock, Par or Stated Value Per Share 0.12 EUR/shares 0%
Deferred Tax Assets, Valuation Allowance 185M USD +42.2%
Deferred Tax Assets, Gross 185M USD +42.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -221M USD -11%
Operating Lease, Liability, Current 181K USD -24.6%
Deferred Tax Assets, Operating Loss Carryforwards 134M USD +76.5%
Unrecognized Tax Benefits 0 USD
Depreciation, Depletion and Amortization 52K USD +247%
Deferred Tax Assets, Net of Valuation Allowance 105K USD +775%
Share-based Payment Arrangement, Expense 54.8M USD +81.5%